CIK 0001812364 · Large accelerated filer
Relay Therapeutics, Inc.
Sign in to watch- Ticker
- RLAY
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-370-8837
- Business address
- 60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $120,165,474
- in 11 filings, $3.7M under 10b5-1 plans
Net −$120,165,474. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 98 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-27 | Catinazzo Thomas Chief Financial Officer | Sale 10b5-1 | −4,566 | $4.42 | $20K | 299,226 |
| 2024-12-27 | Rahmer Peter See remarks | Sale | −400 | $4.38 | $2K | 389,663 |
| 2024-12-16 | Patel Sanjiv President and CEO | Sale 10b5-1 | −100,000 | $5.00 | $500K | 574,548 |
| 2024-10-29 | Catinazzo Thomas Chief Financial Officer | Sale 10b5-1 | −2,300 | $5.95 | $14K | 304,091 |
| 2024-10-28 | Rahmer Peter See remarks | Sale | −1,621 | $6.06 | $10K | 390,063 |
| 2024-10-28 | Catinazzo Thomas Chief Financial Officer | Sale 10b5-1 | −1,697 | $6.06 | $10K | 311,496 |
| 2024-10-28 | Catinazzo Thomas Chief Financial Officer | Sale 10b5-1 | −5,105 | $6.06 | $31K | 306,391 |
| 2024-10-28 | Bergstrom Donald A President, R&D | Sale | −2,688 | $6.06 | $16K | 520,745 |
| 2024-10-28 | Adams Brian Chief Legal Officer | Sale | −1,632 | $6.06 | $10K | 321,907 |
| 2024-09-27 | Rahmer Peter See remarks | Sale | −245 | $7.51 | $2K | 391,684 |
| 2024-09-27 | Catinazzo Thomas Chief Financial Officer | Sale 10b5-1 | −295 | $7.51 | $2K | 319,355 |
| 2024-09-27 | Catinazzo Thomas Chief Financial Officer | Sale 10b5-1 | −6,162 | $7.46 | $46K | 313,193 |
| 2024-09-27 | Bergstrom Donald A President, R&D | Sale | −648 | $7.51 | $5K | 523,433 |
| 2024-09-27 | Adams Brian Chief Legal Officer | Sale | −295 | $7.51 | $2K | 323,539 |
| 2024-07-31 | Rahmer Peter See remarks | Sale 10b5-1 | −13,708 | $8.19 | $112K | 391,929 |
| 2024-07-30 | Rahmer Peter See remarks | Sale 10b5-1 | −15,128 | $8.28 | $125K | 405,637 |
| 2024-07-29 | Catinazzo Thomas Chief Financial Officer | Sale 10b5-1 | −1,702 | $8.85 | $15K | 328,728 |
| 2024-07-29 | Catinazzo Thomas Chief Financial Officer | Sale 10b5-1 | −9,078 | $8.51 | $77K | 319,650 |
| 2024-07-29 | Rahmer Peter See remarks | Sale 10b5-1 | −1,359 | $8.85 | $12K | 432,929 |
| 2024-07-29 | Rahmer Peter See remarks | Sale 10b5-1 | −12,164 | $8.51 | $104K | 420,765 |
Page 8 of 17 · 329 trades